• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, September 11, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

The MIT Press and UC Berkeley launch Rapid Reviews: COVID-19 journal

Bioengineer by Bioengineer
June 29, 2020
in Health
Reading Time: 4 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The new open access, rapid-review overlay journal aims to combat misinformation in COVID-19 research

IMAGE

Credit: The MIT Press

CAMBRIDGE, MA – June 29, 2020–The MIT Press announced today the launch of Rapid Reviews: COVID-19 (RR:C19), an open access, rapid-review overlay journal that will accelerate peer review of COVID-19-related research and deliver real-time, verified scientific information that policymakers and health leaders can use.

Scientists and researchers are working overtime to understand the SARS-CoV-2 virus and are producing an unprecedented amount of preprint scholarship that is publicly available online but has not been vetted yet by peer review for accuracy. Traditional peer review can take four or more weeks to complete, but RR:C19’s editorial team, led by editor-in-chief, Stefano M. Bertozzi, Professor of Health Policy and Management and Dean Emeritus of the School of Public Health at University of California Berkeley, will produce expert reviews in a matter of days.

Using artificial intelligence tools, a global team will identify promising scholarship in preprint repositories, commission expert peer reviews, and publish the results on an open access platform in a completely transparent process. The journal will strive for disciplinary and geographic breadth, sourcing manuscripts from all regions and across a wide variety of fields, including medicine; public health; the physical, biological, and chemical sciences; the social sciences; and the humanities. RR:C19 will also provide a new publishing option for revised papers that are positively reviewed.

Made possible by a $350,000 grant from the Patrick J. McGovern Foundation and hosted on PubPub, an open-source publishing platform from the Knowledge Futures Group for collaboratively editing and publishing journals, monographs, and other open access scholarly content, RR:C19 will limit the spread of misinformation about COVID-19, according to editor-in-chief Bertozzi.

“There is an urgent need to validate–or debunk–the rapidly growing volume of COVID-19-related manuscripts on preprint servers,” explains Bertozzi. “I’m excited to be working with the MIT Press, the Patrick J. McGovern Foundation, and the Knowledge Futures Group to create a novel publishing model that has the potential to more efficiently translate important scientific results into action. We are also working with COVIDScholar, an initiative of UC Berkeley and Lawrence Berkeley National Lab, to create unique AI/machine learning tools to support the review of hundreds of preprints per week.”

“This project signals a breakthrough in academic publishing, bringing together urgency and scientific rigor so the world’s researchers can rapidly disseminate new discoveries that we can trust,” says Vilas Dhar, trustee of the Patrick J. McGovern Foundation. “We are confident the RR:C19 journal will quickly become an invaluable resource for researchers, public health officials, and healthcare providers on the frontline of this pandemic. We’re also excited about the potential for a long-term transformation in how we evaluate and share research across all scientific disciplines.”

On the collaboration around this new journal, Travis Rich, executive director of the Knowledge Futures Group notes, “At a moment when credibility is increasingly crucial to the well-being of society, we’re thrilled to be partnering with this innovative journal to expand the idea of reviews as first-class research objects, both on PubPub and as a model for others.”

Amy Brand, director of the MIT Press sees the no-cost open access model as a way to increase the impact of global research and disseminate high-quality scholarship. “Offering a peer-reviewed model on top of preprints will bring a level of diligence that clinicians, researchers, and others worldwide rely on to make sound judgments about the current crisis and its amelioration,” says Brand. “The project also aims to provide a proof-of-concept for new models of peer-review and rapid publishing for broader applications.”

The editorial board for RR:C19 currently includes Paulin Basinga, Gates Foundation; Nancy Birdsall, Center for Global Development; Jeanine Condo, National University of Rwanda; Robert Gallo, University of Maryland; Dean Jamison, University of Washington; Jerome Kim, International Vaccine Institute; Santiago Levy, The Brookings Institution; Fenyong Liu, UC Berkeley; Felix Masiye, University of Zambia, University of Washington; Jonna Mazet, UC Davis; Shankar Sastry, UC Berkeley; and Mauro Schechter, Federal University of Rio de Janeiro, University of Pittsburgh, Johns Hopkins University. RR:C19 will publish its first reviews in July 2020 and is actively recruiting potential reviewers and contributors.

To learn more about this project, visit: rapidreviewscovid19.mitpress.mit.edu

###

Media Contacts

Jessica Pellien

Associate Director of Publicity

Fortier Public Relations

[email protected]

Emily Paquin Abbas

Communications Coordinator

The MIT Press

[email protected]

About the MIT Press

Established in 1962, the MIT Press is one of the largest and most distinguished university presses in the world and a leading publisher of books and journals at the intersection of science, technology, art, social science, and design. MIT Press books and journals are known for their intellectual daring, scholarly standards, interdisciplinary focus, and distinctive design.

mitpress.mit.edu

About the UC Berkeley School of Public Health

For 75 years and counting, the UC Berkeley SPH has been dedicated to making a transformative impact on the health of populations through its values of health as a right, strength through diversity, think forward, and impact first. To eliminate inequity and injustice that affects the health and dignity of all people, SPH is committed to radical public health collaborations that challenge conventional thinking, leverage technology, and build bridges between research, public policy, education, and action.

publichealth.berkeley.edu

About the Patrick J. McGovern Foundation

The Patrick J. McGovern Foundation is dedicated to improving lives globally with information technology, neuroscience, and AI. The Foundation is the legacy of IDG founder Patrick J. McGovern, who believed in the potential for technology to democratize information, improve the human condition, and advance social good.

mcgovern.org

About the Knowledge Futures Group

The Knowledge Futures Group, a nonprofit originally founded as a partnership between the MIT Press and MIT Media Lab, builds and sustains technology for the production, curation, and preservation of knowledge in service of the public good.

knowledgefutures.org

Media Contact
Emily Paquin-Abbas
[email protected]

Original Source

https://rapidreviewscovid19.mitpress.mit.edu/pub/press-release/release/1

Tags: EducationGrants/FundingGroup OrganizationInfectious/Emerging DiseasesMedicine/HealthPopulation BiologyPublic HealthRobotry/Artificial IntelligenceVirology
Share12Tweet8Share2ShareShareShare2

Related Posts

New Guidelines for Anti-VEGF Therapy in Diabetic Retinopathy

September 11, 2025

Ether-Lipid Buildup Fuels Liver Cancer Progression

September 11, 2025

Veterans Health Administration Clinicians’ Views on Wasteful Services

September 11, 2025

Evaluating Healthcare Impact: A Comprehensive Overview

September 11, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    63 shares
    Share 25 Tweet 16
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Antenatal Origins and Treatments of Neurodevelopment in CHD

Fast Solid-Phase Creation of Crystalline COF Platelets

New Guidelines for Anti-VEGF Therapy in Diabetic Retinopathy

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.